Relmada Therapeutics, Inc. RLMD Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s deferred tax assets and other non-current assets?
- Relmada Therapeutics, Inc. (RLMD) reported deferred tax assets and other non-current assets of $19.5K in Q1 2026.
- How has Relmada Therapeutics, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- Relmada Therapeutics, Inc.'s deferred tax assets and other non-current assets decreased by 11.3% year-over-year, from $21.98K to $19.5K.
- What is the long-term trend for Relmada Therapeutics, Inc.'s deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Relmada Therapeutics, Inc.'s deferred tax assets and other non-current assets has grown at a -23.1% compound annual growth rate (CAGR), from $41K to $11K.